Literature DB >> 3591826

Familial risks of congenital heart defect assessed in a population-based epidemiologic study.

J A Boughman, K A Berg, J A Astemborski, E B Clark, R J McCarter, J D Rubin, C Ferencz.   

Abstract

Congenital heart defects (CHD) represent a heterogeneous group of disorders caused by chromosome abnormalities, mendelian disorders, teratogenic exposures, and unknown etiologic mechanisms. A large group of various isolated defects is presumably multifactorial in origin. Previous studies of familial risks for specific anatomic defects obtained from clinical series may include significant biases and obscured pathogenic relationships. In this population-based study we analyzed all cases of CHD in infants and a control birth cohort in the Baltimore-Washington area. The rates of CHD were defined for first-degree relatives of cases with isolated defects, grouped by a pathogenic classification scheme. Precurrence risks were found to vary among the groups, and risks for flow lesions were higher than previously reported. The sibling precurrence risk for hypoplastic left heart syndrome (13.5%) was not significantly different from that expected for an autosomal recessive mechanism; the risks for different types of ventricular septal defects (VSD) varied among mechanistic groups. The results indicate that the additive multifactorial model does not adequately account for the risks in all forms of isolated CHD of unknown etiology.

Entities:  

Mesh:

Year:  1987        PMID: 3591826     DOI: 10.1002/ajmg.1320260411

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  21 in total

Review 1.  Science, medicine, and the future: Genetics and cardiovascular risk.

Authors:  I N Day; D I Wilson
Journal:  BMJ       Date:  2001-12-15

2.  Recurrence risk figures for isolated tetralogy of Fallot after screening for 22q11 microdeletion.

Authors:  M C Digilio; B Marino; A Giannotti; A Toscano; B Dallapiccola
Journal:  J Med Genet       Date:  1997-03       Impact factor: 6.318

3.  Risk factors for atrial septal defect.

Authors:  J Tikkanen; O P Heinonen
Journal:  Eur J Epidemiol       Date:  1992-07       Impact factor: 8.082

Review 4.  Indications for fetal echocardiography.

Authors:  M Small; J A Copel
Journal:  Pediatr Cardiol       Date:  2004 May-Jun       Impact factor: 1.655

5.  A cluster of hypoplastic left heart malformation in Baltimore, Maryland.

Authors:  K S Kuehl; C A Loffredo
Journal:  Pediatr Cardiol       Date:  2006 Jan-Feb       Impact factor: 1.655

6.  Tricuspid atresia in sibs.

Authors:  A E Lin; L Rosti
Journal:  J Med Genet       Date:  1998-12       Impact factor: 6.318

7.  Tricuspid atresia and annular hypoplasia: report of a familial occurrence.

Authors:  A Kumar; B E Victorica; I H Gessner; J A Alexander
Journal:  Pediatr Cardiol       Date:  1994 Jul-Aug       Impact factor: 1.655

8.  MCTP2 is a dosage-sensitive gene required for cardiac outflow tract development.

Authors:  Seema R Lalani; Stephanie M Ware; Xueqing Wang; Gladys Zapata; Qi Tian; Luis M Franco; Zhengxin Jiang; Kristine Bucasas; Daryl A Scott; Philippe M Campeau; Neil Hanchard; Luis Umaña; Ashley Cast; Ankita Patel; Sau W Cheung; Kim L McBride; Molly Bray; A Craig Chinault; Barbara A Boggs; Miao Huang; Mariah R Baker; Susan Hamilton; Jeff Towbin; John L Jefferies; Susan D Fernbach; Lorraine Potocki; John W Belmont
Journal:  Hum Mol Genet       Date:  2013-06-16       Impact factor: 6.150

9.  Echocardiographic evaluation of asymptomatic parental and sibling cardiovascular anomalies associated with congenital left ventricular outflow tract lesions.

Authors:  Mark B Lewin; Kim L McBride; Ricardo Pignatelli; Susan Fernbach; Ana Combes; Andres Menesses; Wilbur Lam; Louis I Bezold; Norman Kaplan; Jeffrey A Towbin; John W Belmont
Journal:  Pediatrics       Date:  2004-09       Impact factor: 7.124

10.  Preconceptual Folic Acid Use and Recurrence Risk Counseling for Congenital Heart Disease.

Authors:  Shabnam Peyvandi; Jack Rychik; Xuemei Zhang; Judy A Shea; Elizabeth Goldmuntz
Journal:  Congenit Heart Dis       Date:  2014-07-24       Impact factor: 2.007

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.